2117730-84-2
2117730-84-2
Chemical Structure
GW9662-d5
- CAS No.: 2117730-84-2
- Formula:C13H4D5ClN2O3
- Molecular Weight:281.71
IUPAC Name: 2-chloro-5-nitro-N-(phenyl-d5)benzamide
InChIKey: DNTSIBUQMRRYIU-RALIUCGRSA-N
SMILES: ClC1=CC=C(C=C1C(NC2=C(C([2H])=C(C([2H])=C2[2H])[2H])[2H])=O)[N+]([O-])=O
Biological Activity: GW9662-d5 is the deuterium labeled GW9662. GW9662 is a potent and selective PPARγ antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GW9662-d5 | GW9662-d5 is the deuterium labeled GW9662. GW9662 is a potent and selective PPARγ antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
GW9662 (Standard) | 99.92% | GW9662 (Standard) is the analytical standard of GW9662. This product is intended for research and analytical applications. GW9662 is a potent and selective PPARγ antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
GW9662 | 99.98% | GW9662 is a potent and selective PPARγ antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.85
HY-13202T0070907 -
Similarity Score 0.85
HY-W649594NR2F6 modulator-2 -
Similarity Score 0.75
HY-W5206572-Amino-5-nitro-N-(o-tolyl)benzamide -
Similarity Score 0.72
HY-W0115962-Amino-2'-chloro-5-nitrobenzophenone -
Similarity Score 0.71
HY-B21202-Amino-5-nitrobenzophenone -
Similarity Score 0.69
HY-118639CP-74006 -
Similarity Score 0.69
HY-1269442-Aminobenzanilide -
Similarity Score 0.68
HY-W150426Naphthol AS-BS -
Similarity Score 0.68
HY-108422Benodanil -
Explore the MedChemAI to find more analogs
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Leesnitzer LM, et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry. 2002 May 28;41(21):6640-50. [Content Brief]
